Showing results for Precision Health

Researchers have identified a new genetic marker that could play a role in the development of Alzheimer's disease and pave the way for novel therapeutic ...

Researchers at the IU Melvin and Bren Simon Comprehensive Cancer Center are leading the way to improving quality of life and curative chemotherapy doses for ...

IU School of Medicine researchers are leading a multi-site study to use a privacy-preserving artificial intelligence approach to improve breast cancer risk prediction and reduce ...

A new study by IU School of Medicine researchers has found that increased expression of a gene linked to Alzheimer's disease helped improve characteristics of ...

Researchers at Indiana University School of Medicine are co-leading a 5-year, $41 million study to better understand the biological pathways underlying Alzheimer’s disease and ultimately ...

Researchers at IU School of Medicine are learning more about ways to prevent serious side effects from chemotherapy used to treat breast cancer patients.

The second largest federally funded research program at Indiana University School of Medicine will receive $48.8 million over the next five years, fueling the work ...

After a year of work to bring balance to an equation that measures kidney function by removing racial variables, Sharon Moe, MD, associate dean for ...

Using the nation’s largest COVID-19 data resource, a researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center found the COVID-19 vaccine protected ...

Indiana University School of Medicine researchers have discovered an innovative approach to identifying how likely someone is to develop certain diseases.